Sponsored By Stability Biologics, LLC

The STABLECAMP trial is a multicenter, prospective, randomized controlled study evaluating the treatment of non-healing diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). STABLECAMP uses a modified multi-platform (Matriarch) design to compare the results of treating these wounds through standard of care (SOC) combined with multiple cellular, acellular, and matrix-like products (CAMPs) versus SOC alone. This adaptive platform enables comparative analysis across diverse graft technologies and supports the inclusion of additional CAMPs over time.